Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p8
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 8/66)
Character Range: 20924–23826

0     50
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 25 mg  Oral  APO-Diclofenac  TX  MP NP        100  3     50

[60] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
omit:
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 50 mg  Oral  APO-Diclofenac  TX  PDP          50  0     50
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 50 mg  Oral  APO-Diclofenac  TX  MP NP        50  3     50

[61] Schedule 1, Part 1, entry for Digoxin in each of the forms: Paediatric oral solution 50 micrograms per mL, 60 mL; Tablet 62.5 micrograms; and Tablet 250 micrograms
insert in the column headed "Circumstances" (all instances): C15956

[62] Schedule 1, Part 1, entry for Disopyramide in each of the forms: Capsule 100 mg; and Capsule 100 mg (s19A)
insert in the column headed "Circumstances": C15956
[63] Schedule 1, Part 1, entries for Electrolyte replacement, oral in the form Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10
omit from the column headed "Responsible Person" (all instances): AF  substitute (all instances): XT
[64] Schedule 1, Part 1, entry for Entecavir in the form Tablet 0.5 mg (as monohydrate)
omit:
Entecavir  Tablet 0.5 mg (as monohydrate)  Oral  ENTECLUDE  RW  MP NP  C4993 C5036     60  5     30     D(100)

[65] Schedule 1, Part 1, entry for Entecavir in the form Tablet 1 mg (as monohydrate)
omit:
Entecavir  Tablet 1 mg (as monohydrate)  Oral  ENTECLUDE  RW  MP NP  C5037 C5044     60  5     30     D(100)

[66] Schedule 1, Part 1, entry for Entrectinib
omit from the column headed "Circumstances": C13184 C13276 substitute: C13186 C15776
[67] Schedule 1, Part 1, entry for Eptinezumab [Maximum Quantity: 1; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C14189  substitute: C16018
(b) omit from the column headed "Purposes": P14189 substitute: P16018
[68] Schedule 1, Part 1, entries for Estradiol in the form Tablet 2 mg
omit from the column headed "Responsible Person" (all instances): GO  substitute (all instances): XT
[69] Schedule 1, Part 1, after entry for Estradiol in the form Tablet containing estradiol valerate 2 mg [Maximum Quantity: 112; Number of Repeats: 2]
insert:
Estradiol  Transdermal gel 500 micrograms in 0.5 g sachet, 28  Transdermal  Sandrena  OX  MP NP             1  5     1
Estradiol  Transdermal gel 500 micrograms in 0.5 g sachet, 28  Transdermal  Sandrena  OX  MP NP     P14238  2  5     1

[70] Schedule 1, Part 1, after entry for Estradiol in the form Transdermal patches 585 micrograms, 8 [Brand: Estradot 37.5]
insert:
Estradiol  Transdermal patches 585 micrograms, 24 (S19A)  Transdermal  Estramon 37.5 (Germany)  DZ  MP NP        1  1     1

[71] Schedule 1, Part 1, after entry for Estradiol